The board of directors of the SICAV (the “Board”) has recommended that, subject to all relevant regulatory approvals being received, Threadneedle (Lux) Asia Contrarian Equity (the “Portfolio”) will be put into liquidation in accordance with Article 31 of the SICAV’s Articles of Association and the section “Merger or Liquidation” of the Prospectus. Following regulatory approval, this means that the Portfolio’s holdings will be liquidated (i.e. sold).

Further information can be found below:

Shareholder notice